PEVNET is an innovative research program of biobanks and expertise detecting persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes with the main focus in the detection of persistent enterovirus infection leading to inflammation and tissue damage in the pancreas and its role in mediating the inflammatory response that causes type 1 diabetes.
The project runs from 2011 to 2016.
It is a collaborative project funded by the European Union’s (EU) 7th framework programme with 13 project partners from six countries with leading expertise. It is being coordinated by the University of Tampere, Finland.
A causal association between enterovirus and type 1 diabetes has become more and more likely. The aim of PEVNET is to create a new strategy and network of unique resources that make it possible to achieve a breakthrough in the development of new treatment for type 1 diabetes. The main focus is in the detection of persistent enterovirus infection leading to inflammation and tissue damage in the pancreas.
Professor Adrian Bone